Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ChromoGenics is part of the EU's Horizon 2020 project, NewSkin

ChromoGenics is one of the participants in a consortium around the EU project, NewSkin. The project will last for four years and ChromoGenic's part in the project has a contribution of over SEK 2 million.The NewSkin project aims to create what is called an “Open Innovation Test Bed (OITB)” to develop new nano-materials for both industrial and consumer products. The project is expected to last for four years. For ChromoGenic's part, the NewSkin project will use the company's newly acquired and for Northern Europe completely unique sputtering capabilities to produce various new materials.

TI condemns spying on journalists, academics and civil society organisations

Transparency International and Poder Ciudadano, its chapter in Argentina , are deeply concerned at media reports that in 2018 the national intelligence agency was monitoring, gathering information and keeping files on journalists, academics and Civil Society Organisations that apparently registered to participate in World Trade Organisation meetings. This includes intelligence gathered on members of Poder Ciudadano’s own staff. Reports suggest that personal information was collected beyond that publicly available or on official

Trading update

Oslo, Norway (12 June 2020)  - NattoPharma continues to see a strong demand for our products during the second quarter, and we are experiencing Q2 revenue to be in the range of NOK 44-54 million resulting in a H1-2020 revenue in the range of NOK 100-110 million. This is more than 70% growth compared to H1-2019. The Adj. EBITDA margin is expected to be in excess of 15% for H1-2020, compared to the current guiding of 10-15% for the full year. The current performance builds on our confidence to deliver on the guiding for the full year as communicated during the Q1 release. During the second

Tokmanni to open a store in Kalasatama, Helsinki in October – The REDI shopping centre store will be Tokmanni’s ninth store in Helsinki

Tokmanni     Press release     12 June 2020 at 1:00 p.m. Tokmanni , Finland's largest general discount retailer, will open a new and versatile store in the REDI shopping centre  in Kalasatama, Helsinki in October this year. The store will respond to numerous customer requests and increase the number of Tokmanni stores in Helsinki to nine. The Tokmanni located at street level (1st floor) on the Sköne side of the shopping centre will offer a wide and attractive assortment of beauty, health and wellbeing, interior decoration,

Wulff Group Plc completes the repurchases of its own shares

STOCK EXCHANGE RELEASE JUNE 12, 2020 AT 1.00 P.M. Wulff Group Plc completes the repurchases of its own shares. As communicated on May 20, 2020, the Board of Directors of Wulff Group Plc decided to start repurchasing its own shares in accordance with the authorization granted by the Annual General Meeting on April 23, 2020. The repurchases started on May 25, 2020 and ended on June 11, 2020. During this time Wulff Group Plc repurchased 65,260 shares, which corresponds to approximately 0.94% of the total number of Wulff Group Plc shares. The shares were acquired at the market price

Lifting Handicare to better performance: Capital Markets Update 2020

Today, Handicare, a market leader in stairlifts, will arrange a webcasted Capital Markets Update where senior management will elaborate on the company’s strategy and the Lift Up Program.Handicare operates in a growing market with attractive underlying long-term growth fundamentals. The company holds a leading position in Europe within the Accessibility area and has a strong growth trajectory in North America. Performance within the Accessibility business unit has been solid with an organic CAGR of approximately 7 percent over the last five years, and the Group’s financial position is strong.

3Shape Appoints Jakob Just-Bomholt as New Chief Executive Officer

Copenhagen, June 12, 2020: 3Shape today announced that the Company’s Board of Directors has appointed Jakob Just-Bomholt as Chief Executive Officer, effective August 1st. Jakob leaves a position as Executive Vice President of Falck A/S, a global emergency and health care company. Prior to joining Falck in 2017, Jakob worked in various top executive positions at the shipping and logistics company, A.P. Moller-Maersk. 3Shape’s current Co-CEOs and Co-founders Tais Clausen and Nikolaj Deichmann will remain active at 3Shape in new roles as Co-Vice chairmen of the board. Jørgen

DexTech's Phase IIb study for OsteoDex ends with positive follow-up results

The company's randomized Phase IIb study for the treatment of bone metastatic castration-resistant prostate cancer (mCRPC) has now been completed with 2-year follow-up results from the last patients. The primary endpoints of the study concerning markers of bone metabolism have been well achieved. A clear majority of patients showed reduction in their skeletal markers in the blood of the given treatment with OsteoDex. Treatment was very well tolerated  (few and mild side effects)  and good disease-slowing effect was also seen in the lowest doses. The slowing down and decline of the

New agreements signal construction start-up for the next development phase of Oasen Center in Norway

CITYCON OYJ Corporate Press Release 12 June 2020Citycon signs agreements with Bergen municipality for a new health center, and with Veidekke for construction of the next development phase of Oasen Center in Bergen, Norway. Citycon has given the contractor Veidekke the assignment to complete the next phase in the development of Oasen Center in Bergen. Over 6,000 square meters of office space will be converted into premises for a new health center, F&B and daily shopping.“Citycon’s assets are located in the heart of the community, in some of the city’s most dynamic and popular

Regulatory approvals obtained for Atlas Copco’s acquisition of ISRA VISION

Nacka, Sweden, June 12, 2020: With the approval by the Committee on Foreign Investment in the United States (CFIUS) now obtained, all offer conditions for Atlas Copco’s acquisition of ISRA VISION have been fulfilled.The voluntary public takeover offer of the global machine vision specialist was announced February 10, 2020. The settlement of the offer will be completed presumably on June 24, 2020 and in connection with that a payment of MSEK 9 047 (MEUR 860) will be made to ISRA shareholders. Suspension of trading in tendered shares (ISIN DE000A254W60) will presumably take place on June 19,

Annual general meeting in Dampskibsselskabet NORDEN A/S

ANNOUNCEMENT NO. 15 - 12 JUNE 2020 Attached as separate PDF file, please find Chairman of the Board of Directors Klaus Nyborg’s oral report in full from NORDEN's annual general meeting, which is held today 12 June 2020 at 11 am CEST. The Chairman's report and the accompanying presentation (the presentation is only available in Danish) will also be made available at www.ds-norden.com from approximately 11 am CEST. A webcast (in Danish) from the annual general meeting will also be made available today after the general meeting. Kind regards Dampskibsselskabet NORDEN A/S Board

Citycon Oyj: Managers’ Transactions

CITYCON OYJ   Managers’ Transactions   12 June 2020 at 12:00 hrsPerson subject to the notification requirement: Gazit Globe Ltd., Closely associated person(X) Legal personPerson discharging managerial responsibilities in issuer: Chaim Katzman, Chairman of the Board of DirectorsIssuer: Citycon Oyj, LEI 549300P8N0P6KDGTJ206Notification type: initial notificationReference number: 549300P8N0P6KDGTJ206_20200510124929_3(1) TransactionDate: 9 June 2020Venue: NASDAQ HELSINKI LTD (XHEL)Nature of the transaction: acquisitionInstrumentshare (CTY1S)ISIN Code: FI4000369947

Minesto News Update 12 June 2020

· Minesto invited as speaker at EU Sustainable Energy Week · Pareto Securities initiates coverage on Minesto · Photos: Minesto’s first offshore installation phase of the Vestmannasund project · Minesto shortlisted as finalist in the renowned E-Prize awardsMinesto invited as speaker at EU Sustainable Energy Week Minesto’s CEO Dr Martin Edlund has been invited as speaker during the EU Sustainable Energy Week, a month-long series of activities arranged by the European Commission with the purpose to build a secure energy future for Europe. This year’s theme is “Beyond the crisis:

DBP International AB: the subsidiary FarmPharma receives a grant of SEK 300,000

FarmPharma AB (publ), which is a subsidiary of Double Bond Pharmaceutical International AB (publ), have been granted SEK 300,000 by Vinnova in the call “Innovative Startups step 1”. The grant will support ongoing collaboration with Karolinska Institute for the production of starting materials for the company's drug candidate InterferOX. More about collaboration with Karolinska Institutet: https://mb.cision.com/Main/12720/2985377/1157822.pdf More about Vinnova: www.vinnova.se More about FarmPharma: FarmPharma AB (publ) is a subsidiary of Double Bond Pharmaceutical International AB (

New Scientific Publication with Rhinochill System in One of The Most Prestigious High Rank Medical Journal (The Intensive care medicine journal)

The publication, published online today , titled "Time to intra-arrest therapeutic hypothermia in out-of-hospital cardiac arrest patients and its association with neurologic outcome: a propensity matched sub-analysis of the PRINCESS trial" is to be part of the coming June issue of the prestigious Journal of Intensive Care Medicine (impact factor 18.97 in 2018). Intensive Care Medicine is a monthly peer reviewed medical journal covering intensive care or critical care and emergency medicine. The publication authored by the research group of the PRINCESS trial (Dr. Per Nordberg et al) and two

First Episealer® surgery in the Asia-Pacific

Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery with the knee implant Episealer® in the Asia-Pacific region has been scheduled. “This is a significant milestone for us, and we have identified significant opportunities in the Asia-Pacific region. Recently, we have increased our focus towards several new markets, in which the regulatory work is ongoing. Scheduling the first surgery outside of Europe is exciting. We are also happy for the fact that we are reaching commercial milestones, simultaneously as we are making significant progress within the clinical strategy”

Fryshuset and Novare partner to create Skill Shift Initiative Summer providing 1000 summer jobs for Stockholm youth

Several thousand summer jobs have disappeared as a result of the coronavirus crisis. Against this background, the City of Stockholm announced a procurement process open to organizations that are able to offer summer jobs. Fryshuset and Novare entered a bid together. Their bid was successful and now their task is to provide 1000 young people with meaningful employment during the summer of 2020.– As the result of the successful procurement process we can now partner with Fryshuset and Novare to provide 1000 summer jobs for Stockholm area youth. This spring has been a hard one for many young

Enea signs multi-year 5G contract worth up to EUR 24 million

Stockholm, Sweden, June 12, 2020 Enea® (Nasdaq Stockholm: ENEA)  Enea has signed a contract for 5G Cloud Network Data Layer with a Tier 1 European telecom service provider, headquartered in Germany. The contract is expected to generate average annual revenues for Enea of EUR 4-5 million during the contract period, which is up to five years, resulting in a total contract value of EUR 24 million, assuming that the project runs the full term. The main part of the contract relates to software licenses for Enea’s Stratum product. License revenues are recognized when delivery and project

Agreement between Alstom and Snam for the development of hydrogen trains in Italy

Alstom, a global leader in integrated solutions for sustainable mobility, and Snam, one of the world’s leading energy infrastructure companies, have signed a five-year agreement to develop hydrogen trains in Italy.The agreement, after the conclusion of the first phase dedicated to feasibility studies planned in Autumn, aims to develop, already at the beginning of 2021, railway mobility projects including both hydrogen-powered trains and the related technological infrastructure, as well as management and maintenance services.As part of the agreement, Alstom will manufacture and maintain

Cognite convertable loan

As shareholders in Cognite AS (“Cognite”), a company controlled by Aker ASA, Aker Capital AS and Erøy AS have subscribed for investments in a convertible loan to Cognite. Aker Capital AS has subscribed for NOK 82,362,785. Erøy AS, controlled by Øyvind Eriksen, President and CEO of Aker ASA, has subscribed for NOK 1,978,090. The loan may be converted into equity in various defined scenarios. The number of shares which will be issued in a conversion depends on which scenario that triggers the conversion.  In addition to the abovementioned convertible, Aker Capital AS holds 6,791,780

There are no items matching the current filter
There are no more items matching the current filter
Back to top